首页|Otof-/-成年鼠基因治疗DPOAE和ABR阈值变化研究

Otof-/-成年鼠基因治疗DPOAE和ABR阈值变化研究

扫码查看
目的:通过分析Otof-/-成年鼠在基因治疗前后各频率畸变产物耳声发射(distortion product otoa-coustic emissions,DPOAE)和听觉脑干反应(auditory brainstem response,ABR)的阈值变化及其相关性,探索治疗后听力恢复的评价方法.方法:经圆窗膜(round window membrane,RWM)路径,向4周龄Otof-/-成年鼠内耳注射双AAV载体携带的内含肽介导的OTOF基因治疗体系,检测治疗前后DPOAE与ABR阈值,免疫荧光染色评估耳畸蛋白(otoferlin)恢复表达的内耳毛细胞比例及突触数量,并进行统计学分析.结果:AAV-PHP.eB对耳蜗内毛细胞具有高转染率;治疗体系纠正了 Otof-//-成年鼠的听力,且不影响野生型小鼠听功能.基因治疗后DPOAE阈值与ABR阈值变化在16 kHz处存在显著相关;术后DPOAE略微上升,但在术后2个月时出现恢复趋势.结论:基因治疗可显著恢复Otof-/-成年鼠听力,基因治疗体系手术给药可能会引起听力损伤,这需要更加精细、轻柔的操作,以最大程度发挥基因治疗的作用.
Study on gene therapy for DPOAE and ABR threshold changes in adult Otof-/-mice
Objective:This study aims to analyze the threshold changes in distortion product otoacoustic emis-sions(DPOAE)and auditory brainstem response(ABR)in adult Otof-/-mice before and after gene therapy,e-valuating its effectiveness and exploring methods for assessing hearing recovery post-treatment.Methods:At the age of 4 weeks,adult Otof-/-mice received an inner ear injection of a therapeutic agent containing intein-media-ted recombination of the OTOF gene,delivered via dual AAV vectors through the round window membrane(RWM).Immunofluorescence staining assessed the proportion of inner ear hair cells with restored otoferlin ex-pression and the number of synapses.Statistical analysis was performed to compare the DPOAE and ABR thresh-olds before and after the treatment.Results:AAV-PHP.eB demonstrates high transduction efficiency in inner ear hair cells.The therapeutic regimen corrected hearing loss in adult Otof-/-mice without impacting auditory func-tion in wild-type mice.The changes in DPOAE and ABR thresholds after gene therapy are significantly correlated at 16 kHz.Post-treatment,a slight increase in DPOAE was observeds,followed by a recovery trend at 2 months post-treatment.Conclusion:Gene therapy significantly restored hearing in adult Otof-/-mice,though the surgi-cal delivery may cause transient hearing damage.Precise and gentle surgical techniques are essential to maximize gene therapy's efficacy.

OTOFgene therapydistortion product otoacoustic emissionsauditory brainstem response

王子菁、曹麒、胡少伟、范新泰、吕俊、王会、王武庆、李华伟、舒易来

展开 >

南华大学附属第二医院耳鼻喉科(湖南衡阳,421001)

复旦大学附属眼耳鼻喉科医院耳鼻喉科

OTOF 基因治疗 畸变产物耳声发射 听觉脑干反应

国家自然科学基金国家杰出青年科学基金国家重点研发计划湖南省科技创新计划

822250142020YFA09082012023RC4005

2024

临床耳鼻咽喉头颈外科杂志
华中科技大学同济医学院附属协和医院

临床耳鼻咽喉头颈外科杂志

CSTPCD北大核心
影响因子:0.831
ISSN:1001-1781
年,卷(期):2024.38(1)
  • 35